Trial intelligence / Profile preview

Vasopressin and fluid restriction in burn surgery

NCT03590873Unknown

Sponsor
Hallym University Hangang Sacred Heart Hospital
Start
Jul 2018
Primary completion
Jun 2019
Countries
1
01

Overview

Randomised, double-blind trial of vasopressin in burn injury (2 arms), sponsored by Hallym University Hangang Sacred Heart Hospital. Primary endpoint: Intraoperative blood loss at 3 hours. Status: unknown.

02

Drugs

vasopressin
03

Conditions

burn injury

Beyond the preview

Go deeper on NCT03590873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03590873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call